GXH - Green Cross Health Limited (GXH) CEO Resignation

Following the sale of the Medical division, Group CEO Rachael Newfield has resigned and will leave Green Cross Health on 29 January 2027.

Rachael has led Green Cross Health through a significant period of change. This has included the divestment of both the Community Health and Medical divisions and transforming the company into a pharmacy-focused business. Rachael has led investment in initiatives such as the Health Hubs providing a platform for further service expansion and the opportunity for Pharmacy to have an increasing role in the New Zealand health system. The Board thanks her for her contribution and leadership.

With the Group now fully focused on its pharmacy operations, the Board will look to appoint a General Manager Pharmacy to lead the business through its next phase of growth.

John Bolland

Director

• Green Cross Health Limited (GXH) CEO Resignation

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

TRU - Resignation of CEO, Martin Dillon
HGH - Heartland confirms endorsement of TSB Heartland Bank CEO
Devon Funds Morning Note - 02 October 2026
TEM - Transaction in Own Shares
SPK - Notice of Annual Meeting and Proxy Form
October 2nd Morning Report
AFI - Dividend Guidance for FY27 and Move to Quarterly Dividends
SKO - Serko FY27 Interim Results Announcement Date - 16 November
NZK - Proposed Share Transaction Requiring Shareholder Approval
BIF - capital commitment made to BIF